总统唐纳德·特朗普计划在周二签署一项行政命令，优先考虑美国人进入新冠肺炎疫苗在美国帮助其他国家之前，多名白宫官员在周一晚上的背景简报中说。
据官员们透露，特朗普预计将在周二于白宫举行的“新冠肺炎疫苗峰会”上讨论这一命令，两天前，美国食品和药物管理局的顾问将于周四举行公开会议，评估辉瑞疫苗的紧急使用授权。
虽然尚不完全清楚该行政命令具体如何运作，但此举旨在防止美国政府在美国国内所有需求得到满足之前，运送其购买的任何剂量的药物来援助任何外国。
除了行政命令之外，这一事件还将使特朗普再次引起人们对他所说的5月份名为“扭曲速度行动”的努力的成功的关注。
特朗普，副总统迈克·彭斯，卫生与公众服务部部长Alex Azar白宫副新闻秘书布莱恩·摩根斯坦上周告诉美国广播公司新闻，几位州长和私营部门的高管计划参加会议。
“本次峰会的主要目的...一名白宫高级官员说:“我们正在教育美国公众了解疫苗开发过程，以及疫苗分发过程有多广泛，以及一旦疫苗获得美国食品和药物管理局的批准，我们将如何快速到达美国的每个邮编。”。
这位官员补充说，峰会旨在“灌输对这两个过程的信心，以便美国人知道疫苗是安全的，并且他们知道每个社区都在非常全面地考虑我们如何解决这个问题。”
“这真的是二战以来最壮观的动员，”这位官员夸口道。"比以往任何时候都更快地将疫苗推向市场."
根据拜登过渡官员的说法，拜登过渡团队没有人被邀请。
新冠肺炎疫苗的两个主要开发商莫德纳和辉瑞公司最初参与了与白宫的讨论，以参加此次峰会，但白宫官员坚称，一旦美国食品和药物管理局生物制品中心主任彼得·马克斯(Peter Marks)证实他将参加此次活动，政府决定不将他们包括在内。
一名白宫高级官员告诉记者:“鉴于监管机构将参与此次活动，我们改变了方向。”。“在美国食品和药物管理局也参与该活动之前，不要让一家或多家疫苗公司的申请悬而未决，这更为合适。”
白宫官员还否认了一份报告，即政府去年夏天拒绝了从辉瑞公司额外购买4亿剂疫苗的提议。
“我告诉你，这是假的，”一名白宫高级官员声称，并补充说，政府不愿意在没有确保首先获得授权的情况下购买更多疫苗剂量。“我还会告诉你，我们现在正在进行谈判，我们不能公开谈论这件事，但我们绝对有信心获得我们已经签约的疫苗剂量，我们将有足够的剂量在2021年第二季度结束前为所有希望接种疫苗的美国人接种疫苗。”
辉瑞在对美国广播公司新闻的一份声明中表示，该公司“无法对可能与美国政府进行的任何保密讨论发表评论”，但承诺“尽可能快速、高效和公平地”提供疫苗。
辉瑞公司的一名代表表示:“美国政府最初订购了1亿剂辉瑞-生物技术公司的新冠肺炎疫苗，辉瑞公司准备在收到美国食品和药物管理局的紧急使用授权后不久开始运送初始剂量。”"超过1亿的任何额外剂量都要经过单独的、双方都能接受的协议."
国家过敏和传染病研究所所长安东尼·福奇博士也预计不会参加峰会。
“我不能去那里，因为我们在国立卫生研究院有事情，”福奇周一早上告诉CNN。“但很明显，可以说我是一名运动员，因为我们研究所非常积极地参与了疫苗的开发。因此，你将看到的是一项非常成功的工作的展开。”
一名白宫官员证实福奇被“邀请”，但称是“日程冲突”
“他在这个问题上是一个主要的声音，在疫苗信心上是一个值得信任的声音，所以他本来想参加，我们也欢迎参加，但是由于一个重要的日程安排问题，不幸的是，他没能参加，”一名白宫官员说。
undefined更多:关于冠状病毒的最新新闻和视频
白宫表示，三名共和党州长计划参加峰会，包括德克萨斯州州长格雷格·艾伯特(Greg Abbott)、佛罗里达州州长罗恩·德桑蒂斯(Ron DeSantis)和田纳西州州长比尔·李(Bill Lee)，以及路易斯安那州民主党州长约翰·贝尔·爱德华兹(John Bel Edwards)。
“他将分享田纳西州新冠肺炎疫苗分发计划的信息，类似于上周四在孟菲斯与副总统彭斯、国务卿阿扎尔和主任雷德菲尔德举行的曲速行动圆桌会议上讨论的内容，”李发言人吉勒姆·弗格森告诉美国广播公司新闻。
当被问及特朗普总统是否考虑在电视直播中接受疫苗时，一名白宫官员表示，“这肯定是正在考虑的事情”，但他补充说，由于总统已经有了新冠肺炎并康复，他“不是接受疫苗的高度优先考虑对象”。
At 'vaccine summit,' Trump set to issue order that Americans get 1st access
PresidentDonald Trumpplans to sign an executive order on Tuesday that would prioritize Americans’ access to COVID-19vaccinesbefore the United States helps other countries, multiple White House officials said during a background briefing Monday evening.
Trump is expected to discuss the order at a "COVID-19 Vaccine Summit" he is holding at the White House on Tuesday, according to the officials, two days before advisers to the Food and Drug Administration hold a public meeting Thursday to assess the Pfizer vaccine for emergency use authorization.
While it’s not entirely clear on how exactly the executive order would work, the move is designed to prevent the U.S. government from shipping any doses it has purchased to aid any foreign countries until all needs are met within the United States.
Beyond the executive order, the event will allow Trump to again call attention to the success of the effort he says he named "Operation Warp Speed" in May.
Trump, Vice President Mike Pence, Health and Human Services SecretaryAlex Azar, several governors, and executives from the private sector plan to participate in the meeting, White House deputy press secretary Brian Morgenstern told ABC News last week.
"The key purposes of this summit ... is educating the American public about the vaccine development process and how extensive it is as well as the vaccine distribution process and how we will reach every zip code in America very quickly as soon as a vaccine is approved by the FDA," one senior White House official said.
The official added that the summit is intended to "instill confidence in both of those processes so that Americans know that the vaccine is safe and so that they know that every community is being considered very thoroughly in how we get this out."
"It's really the most spectacular mobilization since World War II," the official boasted. "To get a vaccine to market much, much faster than has ever been done before."
No one from the Biden transition team was invited, according to a Biden transition official.
Two leading developers of a COVID-19 vaccine, Moderna and Pfizer, were initially involved in discussions with the White House to participate in the summit, but White House officials asserted that the administration decided not to include them once Peter Marks, the director of the Center for Biologics at the FDA, confirmed he would participate in the event.
"There was a change of direction in light of the fact that we would have the regulator participating in the event," one senior White House official told reporters. "It was more appropriate not to have one or more vaccine companies with pending applications before the FDA also participating in that event."
White House officials also denied a report that the administration turned down an offer last summer to purchase an additional 400 million doses of the vaccine from Pfizer.
"I'll tell you that's false," one senior White House official claimed, adding the administration was not willing to buy more vaccine doses without making sure it was authorized first. "I'll also tell you we're in the middle of negotiations right now, and we can't talk publicly about it but we feel absolutely confident we will get the vaccine doses for which we've contracted, and we'll have sufficient number of doses to vaccinate all Americans who desire one before the end of the second quarter of 2021."
In a statement to ABC News, Pfizer said the company "is not able to comment on any confidential discussions that may be taking place with the U.S. government," but pledged to make the vaccine available "as quickly, efficiently, and equitably as possible."
"The U.S. government placed an initial order of 100 million doses for Pfizer-BioNTech’s COVID-19 vaccine, and Pfizer is ready to begin shipping initial doses soon after receiving an Emergency Use Authorization from the FDA," a representative from Pfizer stated. "Any additional doses beyond the 100 million are subject to a separate and mutually-acceptable agreement."
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, is also not expected to join the summit.
"I'm not going to be able to be there for reasons that we have something here at the NIH,” Fauci told CNN on Monday morning. “But obviously, I'm a player, as it were, since our institute was very much involved in the development of a vaccine. So what you're going to be seeing is the rolling out of what is a very successful effort."
A White House official confirmed Fauci was "invited" but cited a "scheduling conflict."
"He is a leading voice on this issue and a trusted voice on vaccine confidence, so he would have liked to participate and we would have welcomed participation, but due to an important scheduling issue, he just couldn’t make it, unfortunately," one of the White House officials said.
Three Republican governors are scheduled to participate in the summit, including Texas Gov. Greg Abbott, Florida governor Ron DeSantis, and Tennessee Gov. Bill Lee, as well as Louisiana Democratic Gov. John Bel Edwards according to the White House.
“He'll be sharing information on Tennessee's COVID-19 vaccine distribution plan, similar to what was discussed at last Thursday's Operation Warp Speed roundtable in Memphis with Vice President Pence, Secretary Azar, and Director Redfield,” Lee spokesman Gillum Ferguson told ABC News.
Asked whether President Trump is considering receiving the vaccine on live television, a White House official said that is "certainly something that is under consideration," but added that since the president has already had COVID-19 and recovered, he is "not a high priority for receiving the vaccine."
